Navigation Links
Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®
Date:4/21/2011

ST. LOUIS, April 21, 2011 /PRNewswire/ -- Fleming Pharmaceuticals, maker of ThyroShield®– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.  

ThyroShield is an over-the-counter iodide solution which, when taken orally, saturates the thyroid gland so radioactive iodine cannot be absorbed. ThyroShield is especially effective for babies and children, who are most at risk during radiation exposure.

"The March 11 incident at Japan's Fukushima Daiichi power plant has increased awareness of the need for preparedness in the event of a major nuclear emergency," stated Phill Dritsas, president of Fleming Pharmaceuticals. "Based on the number of inquiries we have received in the past month from governments, hospitals and others around the world, it is clear to us that we need to do everything within our power here at Fleming to help meet the need for global and domestic relief. We've responded by taking steps to ensure that we can significantly increase production of ThyroShield."  

Working closely with the FDA, Fleming Pharmaceuticals has qualified a new potassium iodide (KI) supplier to ensure a steady supply of quality raw materials to manufacture ThyroShield. The company has also established new agreements with vendors to shorten lead times needed to complete orders for ThyroShield package components such as bottles, caps and droppers. Finally, Fleming Pharmaceuticals has completed a thorough audit to identify production line logistics that can be immediately implemented to fulfill any significant new orders for ThyroShield.

"ThyroShield was developed under the Orphan Drug Act – a federal law designed to encourage the development of pharmaceuticals that have limited commercial potential," Dritsa
'/>"/>

SOURCE Fleming Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Media Statement on Nuclear Crisis in Japan: Fleming Pharmaceuticals Stepping Up Production of Nuclear Antidote
2. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
3. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
4. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
5. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care Conference
7. Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering
8. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
9. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
10. Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award
11. Sigma-Tau Pharmaceuticals Announces Approval for New Manufacturing Process for ONCASPAR® (Pegaspargase) Primary Ingredient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... HARRISBURG, Pa. , Dec. 24, 2014  Commonwealth Cornerstone ... New Markets Tax Credits transaction on Tuesday to help fund ... Health Network (PHN) in Sharon . ... operating in Pennsylvania . It is the ... district, with more than 150 people on staff. ...
(Date:12/24/2014)... , Dec. 24, 2014  The International Trade Commission (ITC) ... (RMD) against BMC Medical. In a notice issued on December ... that ResMed,s patent on its humidifier was invalid. ... "monumental win". "We are very excited with the ITC,s decision ... that we have taken since the very beginning on the ...
(Date:12/24/2014)... , December 24, 2014 ... at an average rate of 8.1%. The US has ... knee and spine surgeries are the common orthopedic procedures ... have a lower penetration. Increased number of product recalls ... Non-metallic orthopedic devices have gained popularity in the industry ...
Breaking Medicine Technology:Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
(Date:12/24/2014)... (PRWEB) December 24, 2014 New studies reveal ... to hearing loss related depression (March 6, 2014, JAMA Otolaryngology*). ... gradual hearing loss (about 50 percent according to recent polls) ... effect on how a person feels and relates to the ... overall improvements are also made by way of:, ...
(Date:12/24/2014)... December 24, 2014 The federal ... allege the blood thinner caused life-threatening episodes of ... leadership structure for the proceeding, Bernstein Liebhard LLP ... the Court plans to select lawyers to serve ... plans on appointing a Plaintiffs’ Steering Committee, which ...
(Date:12/24/2014)... Today, Yunx.co.uk, a hot style dress supplier ... special occasion outfits, unveils 65 new bridesmaid dresses ... discounted prices, up to 80% off. , Yunx.co.uk’s dresses ... fashionable designs, gorgeous looks and delicate craftsmanship. These new ... devoted to designing and offering high-quality women’s dresses with ...
(Date:12/24/2014)... Mike Billings , PT, MS, CEEAA, President ... PT, MBA, GCS, Director of Professional Development to discuss ... of the Improving Medicare Post-Acute Care Transformation Act ... the Infinicast, the two leaders discuss how the IMPACT ... to standardize post-acute assessment data for quality, payment, and ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, ... from sex for one year will be allowed to donate blood ... reverse a 31-year ban on donations from men who have sex ... its intention to release a new draft guidance in early 2015 ... men. The FDA is changing its policy based on data ...
Breaking Medicine News(10 mins):Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3
... Director of the Lucero Latino Mental Health Training Program at ... was appointed today to the Massachusetts Health Disparities Council by ... of the Health Disparities Council. , , ... to be named to the Council, which was established by ...
... N.J., Dec. 15 Daiichi Sankyo, Inc., announced ... hypertension disease management program developed in accordance with ... Certification from the National Committee for Quality Assurance ... health care quality. NCQA certification signifies that the ...
... M.D. Anderson Cancer Center To Evaluate Surgery vs. CyberKnife ... ... 15, 2008 -- CyberKnife Center of Palm Beach, http://www.cyberknifepalmbeach.com , ... landmark study comparing traditional surgery and CyberKnife® radiosurgery treatment outcomes in ...
... Dec. 15 "We believe that hair loss for,both men ... was to find a,non-surgical approach to help our clients that ... We selected the Revage 670(TM),because it is the only ... proved it works (supported by Harvard Medical, Northwestern,University , ...
... 15 DaVita Inc.,(NYSE: DVA ), today ... of,Health and Human Services, Office of Inspector General ("OIG") ... connection with the civil,investigation by the Department of Justice ... Georgia previously reported in the Company,s,Quarterly Report on 10-Q ...
... than during the day, study says , , MONDAY, Dec. 15 ... sick body good, new research says. , Stanford University research ... bacteria the hardest at night and the least during the ... American Society for Cell Biology annual meeting, in San Francisco. ...
Cached Medicine News:Health News:Latino Psychologist Appointed to Mental Health Post in Commonwealth 2Health News:Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program 2Health News:Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program 3Health News:First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients 2Health News:First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients 3Health News:DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation 2Health News:Immune System Works Better at Night 2
The HT-PB is a implantable bipolar tined permanent pacing lead for stimulation of the ventricle....
The Guidant Fineline leads are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
Steroid-eluting, screw-in pacing lead...
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
Medicine Products: